Chronic uremia and the exposure to dialysis solutions during peritoneal dialysis (PD) induce peritoneal alterations. Using a long-term peritoneal exposure model, we compared the effects of chronic kidney failure (CKD) itself and exposure to either a ‘conventional’ or a ‘biocompatible’ dialysis solution on peritoneal morphology and function.
Methods
Wistar rats (Harlan, Zeist, the Netherlands) were grouped into: normal kidney function (NKF), CKD induced by 70% nephrectomy, CKD receiving daily peritoneal infusions with 3.86% glucose Dianeal (CKDD), or Physioneal (both solutions from Baxter Healthcare, Castlebar, Ireland) (CKDP). At 16 weeks, a peritoneal function test was performed, and histology, ultrastructure, and hydroxyproline content of peritoneal tissue were assessed.
Results
Comparing CKD with NKF, peritoneal transport rates were higher, mesothelial cells (MC) displayed increased number of microvilli, blood and lymph vasculature expanded, vascular basal lamina appeared thicker, with limited areas of duplication, and fibrosis had developed. All alterations, except lymphangiogenesis, were enhanced by exposure to both dialysis fluids. Distinct MC alterations were observed in CKDD and CKDP, the latter displaying prominent basolateral protrusions. In addition, CKDP was associated with a trend towards less fibrosis compared to CKDD.
Conclusions
Chronic kidney failure itself induced peritoneal alterations, which were in part augmented by exposure to glucose-based dialysis solutions. Overall, the conventional and biocompatible solutions had similar long-term effects on the peritoneum. Importantly, the latter may attenuate the development of fibrosis.
KredietR.T., StruijkD.G.Peritoneal changes in patients on long-term peritoneal dialysis.Nat Rev Nephrol2013; 9: 419–29.
2.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
3.
KredietR.T., van WestrhenenR., ZweersM.M., StruijkD.G.Clinical advantages of new peritoneal dialysis solutions.Nephrol Dial Transplant2002; 17(Suppl 3): 16–8.
PerlJ., NessimS.J., BargmanJ.M.The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?Kidney Int2011; 79: 814–24.
6.
HekkingL.H., ZareieM., DriesprongB.A., FaictD., WeltenA.G., de GreeuwI.Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.J Am Soc Nephrol2001; 12: 2775–86.
7.
KimC.D., KwonH.M., ParkS.H., OhE.J., KimM.H., ChoiS.Y.Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.Ther Apher Dial2007; 11: 56–64.
8.
KredietR.T., ZweersM.M., van WestrhenenR., ZegwaardA., StruijkD.G.Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?NDT Plus2008; 1: 56–62.
9.
MortierS., FaictD., LameireN.H., De VrieseA.S.Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.Kidney Int2005; 67: 1559–65.
10.
ZareieM., KeuningE.D., ter WeeP.M., SchalkwijkC.G., BeelenR.H., van den BornJ.Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.Nephrol Dial Transplant2006; 21: 208–16.
11.
MortierS., FaictD., SchalkwijkC.G., LameireN.H., De VrieseA.S.Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane.Kidney Int2004; 66: 1257–65.
12.
de GraaffM., ZegwaardA.H., ZweersM.M., VlijmA., de WaartD.R., VandemaeleF.The effects of a dialysis solution with a combination of glycerol/ amino acids/dextrose on the peritoneal membrane in chronic renal failure.Perit Dial Int2010; 30: 192–200.
13.
van WestrhenenR., ZweersM.M., KunneC., de WaartD.R., van der WalA.C., KredietR.T.A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.Perit Dial Int2008; 28: 487–96.
14.
ZweersM.M., SplintL.J., KredietR.T., StruijkD.G.Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat.Nephrol Dial Transplant2001; 16: 651–4.
15.
CombetS., FerrierM.L., Van LandschootM., StoenoiuM., MoulinP., MiyataT.Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum.J Am Soc Nephrol2001; 12: 2146–57.
16.
VrtovsnikF., CoesterA.M., Lopes-BarretoD., de WaartD.R., Van der WalA.C., StruijkD.G.Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.Perit Dial Int2010; 30: 558–69.
17.
FarrisA.B., AlpersC.E.What is the best way to measure renal fibrosis?: a pathologist's perspective.Kidney Int Suppl2014; 4: 9–15.
18.
GundersenH.J., BendtsenT.F., KorboL., MarcussenN., MollerA., NielsenK.Some new, simple and efficient stereological methods and their use in pathological research and diagnosis.Apmis1988; 96: 379–94.
19.
SundS., GrimmP., ReisæterA.V., HovigT.Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis.Nephrol Dial Transplant2004; 19: 2838–45.
20.
MatsuiK., Nagy-BojarskyK., LaakkonenP., KriegerS., MechtlerK., UchidaS.Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase P and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels.J Am Soc Nephrol2003; 14: 1981–9.
21.
van WestrhenenR., WestraW.M., van den BornJ., KredietR.T., KeuningE.D., HiralallJ.Alpha-2-macroglobulin and albumin are useful serum proteins to detect subclinical peritonitis in the rat.Perit Dial Int2006; 26: 101–7.
22.
PannekeetM.M., ImholzA.L., StruijkD.G., KoomenG.C., LangedijkM.J., SchoutenN.The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.Kidney Int1995; 48: 866–75.
23.
SmitW., van DijkP., LangedijkM.J., SchoutenN., van den BergN., StruijkD.G.Peritoneal function and assessment of reference values using a 3.86% glucose solution.Perit Dial Int2003; 23: 440–9.
24.
DrachenbergC.B., SteinbergerE., Hoehn-SaricE., HeffesA., KlassenD.K., BartlettS.T.Specificity of inter tubular capillary changes: comparative ultrastructural studies in renal allografts and native kidneys.Ultrastruct Pathol1997; 21: 227–33.
25.
MutsaersS.E.Mesothelial cells: their structure, function and role in serosal repair.Respirology2002; 7: 171–91.
26.
WilliamsJ.D., CraigK.J., von RuhlandC., TopleyN., WilliamsG.T.The natural course of peritoneal membrane biology during peritoneal dialysis.Kidney Int Suppl2003; (88): S43–9.
27.
DobbieJ.W., ZakiM., WilsonL.Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis.Scott Med J1981; 26: 213–23.
28.
DobbieJ.W.Morphology of the peritoneum in CAPD.Blood Purif1989; 7: 74–85.
29.
GotloibL., ShostackA., Bar-SellaP., CohenR.Continuous mesothelial cell injury and regeneration during long-term peritoneal dialysis.Perit Dial Int1987; 7: 148–56.
30.
SlaterN.D., CopeG.H., RafteryA.T.Mesothelial hyperplasia in response to peritoneal dialysis fluid: a morphometric study in the rat.Nephron1991; 58: 466–71.
31.
Yanez-MoM., Lara-PezziE., SelgasR., Ramirez-HuescaM., Dominguez-JimenezC., Jimenez-HeffernanJ.A.Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.N Engl J Med2003; 348: 403–13.
TopleyN.Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions.Adv Ren Replace Ther1998; 5: 179–84.
34.
VisserC.E., Brouwer-SteenbergenJ.J., BetjesM.G., KoomenG.C., BeelenR.H., KredietR.T.Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.Nephrol Dial Transplant1995; 10: 64–9.
35.
KawanishiK., HondaK., TsukadaM., OdaH., NittaK.Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.Perit Dial Int2013; 33: 242–51.
36.
RubinJ., RustP., BrownP., PopovichR.P., NolphK.D.A comparison of peritoneal transport in patients with psoriasis and uremia.Nephron1981; 29: 185–9.
37.
ChoiH.Y., KimD.K., LeeT.H., MoonS.J., HanS.H., LeeJ.E.The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.Perit Dial Int2008; 28: 174–82.
38.
TranaeusA.A long-term study of a bicarbonate/lactate-based peritoneal dialysis solution—clinical benefits. The Bicarbonate/Lactate Study Group.Perit Dial Int2000; 20: 516–23.
39.
JohnsonD.W., BrownF.G., ClarkeM., BoudvilleN., EliasT.J., FooM.W.The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.Nephrol Dial Transplant2012; 27: 4445–53.
40.
BosW.J., DemircanM.M., WeeningJ.J., KredietR.T., van der WalA.C.Renal vascular changes in renal disease independent of hypertension.Nephrol Dial Transplant2001; 16: 537–41.
41.
FabbriniP., SchilteM.N., ZareieM., ter WeeP.M., KeuningE.D., BeelenR.H.J.Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis.Nephrol Dial Transplant2009; 24: 3669–76.
42.
GuoJ., XiaoJ., GaoH., JinY., ZhaoZ., JiaoW.Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.J Surg Res2014; 188: 527–36.
43.
XiaoJ., GaoH., JinY., ZhaoZ., GuoJ., LiuZ.The abnormal expressions of tristetraprolin and the VEGF family in uraemic rats with peritoneal dialysis.Mol Cell Biochem2014; 392: 229–38.
44.
MichelsW.M., ZweersM.M., SmitW., KorevaarJ., StruijkD.G., van WestrhenenR.Does lymphatic absorption change with the duration of peritoneal dialysis?Perit Dial Int2004; 24: 347–52.
45.
FlessnerM.F., CreditK., HendersonK., VanpeltH.M., PotterR., HeZ.Peritoneal changes after exposure to sterile solutions by catheter.J Am Soc Nephrol2007; 18: 2294–302.
46.
JunqueiraL.C., BignolasG., BrentaniR.R.Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections.Histochem J1979; 11: 447–55.
47.
LattoufR., YounesR., LutomskiD., NaamanN., GodeauG., SenniK.Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues.J Histochem Cytochem2014; 62: 751–8.
